CALLOS ANDREW (Chief Commercial Officer) sold 21.3% of their position (15.86K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $1.03M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001061983-26-000046
Officer· Chief Commercial Officer
Since Mar 2021
-15.86K
Net shares
Net seller
$1.03M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.86K acquired · 31.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.86K
Price / share
$37.63
Trade value
$596.70K
% of position
27.1%
5/1/2026
58.55K→74.41K
Common Stock
Direct
Shares
−15.86K
Price / share
$65.00
Trade value
$1.03M
% of position
21.3%
5/1/2026
74.41K→58.55K
Total
Net shares
+0.00
Net value
-$434.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +15.86K | $37.63 | $596.70K | 27.1% | 58.55K | 74.41K |
| Common Stock Direct | 5/1/2026 | S · Sale | −15.86K | $65.00 | $1.03M | 21.3% | 74.41K | 58.55K |
| Total | +0.00 | -$434.01K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15.86K shares
Shares
−15.86K
Strike price
37.63
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock15.86K shares | 5/1/2026 | M · Option Exercise | −15.86K | 37.63 | — | 0.00 |